ACADIA Pharmaceuticals Inc (MEX:ACAD)
MXN 509 0 (0%) Market Cap: 50.07 Bil Enterprise Value: 41.15 Bil PE Ratio: 83.33 PB Ratio: 4.82 GF Score: 75/100

ACADIA Pharmaceuticals Inc at Cowen Health Care Conference (Virtual) Transcript

Mar 09, 2022 / 07:50PM GMT
Release Date Price: MXN466.2
Ritu Subhalaksmi Baral
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Good afternoon, everyone. Thanks for joining us on this home stretch of the Cowen 2022 Healthcare Conference for the ACADIA fireside chat.

I'm covering analyst, Ritu Baral, and I'd like to welcome the ACADIA team for the time. Thank you so much. We have Steve Davis, CEO; Serge Stankovic, President; and -- gosh, Serge wears -- you wear so many hats, I can't even remember all of your titles now. I do remember your newly appointed President, Mark Schneyer, CFO; and Chief Commercial Officer, Brendan Teehan.

Welcome, everyone. Steve, you had some news this morning. So I'm going to turn it over to you for just a couple of minutes to make some introductory remarks before we go into Q&A.

Stephen R. Davis
ACADIA Pharmaceuticals Inc. - CEO & Director

That sounds great. Ritu. Thanks much for having us, and thanks to each of you for joining today. I'll try to do this quickly, but I would like to level set a little bit.

To deliver

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot